Cargando…

How Curcumin Targets Inflammatory Mediators in Diabetes: Therapeutic Insights and Possible Solutions

Diabetes mellitus is a multifactorial chronic metabolic disorder, characterized by altered metabolism of macro-nutrients, such as fats, proteins, and carbohydrates. Diabetic retinopathy, diabetic cardiomyopathy, diabetic encephalopathy, diabetic periodontitis, and diabetic nephropathy are the promin...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussain, Yaseen, Khan, Haroon, Alotaibi, Ghallab, Khan, Fazlullah, Alam, Waqas, Aschner, Michael, Jeandet, Philippe, Saso, Luciano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268477/
https://www.ncbi.nlm.nih.gov/pubmed/35807304
http://dx.doi.org/10.3390/molecules27134058
_version_ 1784743992803459072
author Hussain, Yaseen
Khan, Haroon
Alotaibi, Ghallab
Khan, Fazlullah
Alam, Waqas
Aschner, Michael
Jeandet, Philippe
Saso, Luciano
author_facet Hussain, Yaseen
Khan, Haroon
Alotaibi, Ghallab
Khan, Fazlullah
Alam, Waqas
Aschner, Michael
Jeandet, Philippe
Saso, Luciano
author_sort Hussain, Yaseen
collection PubMed
description Diabetes mellitus is a multifactorial chronic metabolic disorder, characterized by altered metabolism of macro-nutrients, such as fats, proteins, and carbohydrates. Diabetic retinopathy, diabetic cardiomyopathy, diabetic encephalopathy, diabetic periodontitis, and diabetic nephropathy are the prominent complications of diabetes. Inflammatory mediators are primarily responsible for these complications. Curcumin, a polyphenol derived from turmeric, is well known for its anti-oxidant, anti-inflammatory, and anti-apoptotic properties. The regulation of several signaling pathways effectively targets inflammatory mediators in diabetes. Curcumin’s anti-inflammatory and anti-oxidative activities against a wide range of molecular targets have been shown to have therapeutic potential for a variety of chronic inflammatory disorders, including diabetes. Curcumin’s biological examination has shown that it is a powerful anti-oxidant that stops cells from growing by releasing active free thiol groups at the target location. Curcumin is a powerful anti-inflammatory agent that targets inflammatory mediators in diabetes, and its resistant form leads to better therapeutic outcomes in diabetes complications. Moreover, Curcumin is an anti-oxidant and NF-B inhibitor that may be useful in treating diabetes. Curcumin has been shown to inhibit diabetes-related enzymes, such as a-glucosidase, aldose reductase and aldose reductase inhibitors. Through its anti-oxidant and anti-inflammatory effects, and its suppression of vascular endothelial development and nuclear transcription factors, curcumin has the ability to prevent, or reduce, the course of diabetic retinopathy. Curcumin improves insulin sensitivity by suppressing phosphorylation of ERK/JNK in HG-induced insulin-resistant cells and strengthening the PI3K-AKT-GSK3B signaling pathway. In the present article, we aimed to discuss the anti-inflammatory mechanisms of curcumin in diabetes regulated by various molecular signaling pathways.
format Online
Article
Text
id pubmed-9268477
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-92684772022-07-09 How Curcumin Targets Inflammatory Mediators in Diabetes: Therapeutic Insights and Possible Solutions Hussain, Yaseen Khan, Haroon Alotaibi, Ghallab Khan, Fazlullah Alam, Waqas Aschner, Michael Jeandet, Philippe Saso, Luciano Molecules Article Diabetes mellitus is a multifactorial chronic metabolic disorder, characterized by altered metabolism of macro-nutrients, such as fats, proteins, and carbohydrates. Diabetic retinopathy, diabetic cardiomyopathy, diabetic encephalopathy, diabetic periodontitis, and diabetic nephropathy are the prominent complications of diabetes. Inflammatory mediators are primarily responsible for these complications. Curcumin, a polyphenol derived from turmeric, is well known for its anti-oxidant, anti-inflammatory, and anti-apoptotic properties. The regulation of several signaling pathways effectively targets inflammatory mediators in diabetes. Curcumin’s anti-inflammatory and anti-oxidative activities against a wide range of molecular targets have been shown to have therapeutic potential for a variety of chronic inflammatory disorders, including diabetes. Curcumin’s biological examination has shown that it is a powerful anti-oxidant that stops cells from growing by releasing active free thiol groups at the target location. Curcumin is a powerful anti-inflammatory agent that targets inflammatory mediators in diabetes, and its resistant form leads to better therapeutic outcomes in diabetes complications. Moreover, Curcumin is an anti-oxidant and NF-B inhibitor that may be useful in treating diabetes. Curcumin has been shown to inhibit diabetes-related enzymes, such as a-glucosidase, aldose reductase and aldose reductase inhibitors. Through its anti-oxidant and anti-inflammatory effects, and its suppression of vascular endothelial development and nuclear transcription factors, curcumin has the ability to prevent, or reduce, the course of diabetic retinopathy. Curcumin improves insulin sensitivity by suppressing phosphorylation of ERK/JNK in HG-induced insulin-resistant cells and strengthening the PI3K-AKT-GSK3B signaling pathway. In the present article, we aimed to discuss the anti-inflammatory mechanisms of curcumin in diabetes regulated by various molecular signaling pathways. MDPI 2022-06-24 /pmc/articles/PMC9268477/ /pubmed/35807304 http://dx.doi.org/10.3390/molecules27134058 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Hussain, Yaseen
Khan, Haroon
Alotaibi, Ghallab
Khan, Fazlullah
Alam, Waqas
Aschner, Michael
Jeandet, Philippe
Saso, Luciano
How Curcumin Targets Inflammatory Mediators in Diabetes: Therapeutic Insights and Possible Solutions
title How Curcumin Targets Inflammatory Mediators in Diabetes: Therapeutic Insights and Possible Solutions
title_full How Curcumin Targets Inflammatory Mediators in Diabetes: Therapeutic Insights and Possible Solutions
title_fullStr How Curcumin Targets Inflammatory Mediators in Diabetes: Therapeutic Insights and Possible Solutions
title_full_unstemmed How Curcumin Targets Inflammatory Mediators in Diabetes: Therapeutic Insights and Possible Solutions
title_short How Curcumin Targets Inflammatory Mediators in Diabetes: Therapeutic Insights and Possible Solutions
title_sort how curcumin targets inflammatory mediators in diabetes: therapeutic insights and possible solutions
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268477/
https://www.ncbi.nlm.nih.gov/pubmed/35807304
http://dx.doi.org/10.3390/molecules27134058
work_keys_str_mv AT hussainyaseen howcurcumintargetsinflammatorymediatorsindiabetestherapeuticinsightsandpossiblesolutions
AT khanharoon howcurcumintargetsinflammatorymediatorsindiabetestherapeuticinsightsandpossiblesolutions
AT alotaibighallab howcurcumintargetsinflammatorymediatorsindiabetestherapeuticinsightsandpossiblesolutions
AT khanfazlullah howcurcumintargetsinflammatorymediatorsindiabetestherapeuticinsightsandpossiblesolutions
AT alamwaqas howcurcumintargetsinflammatorymediatorsindiabetestherapeuticinsightsandpossiblesolutions
AT aschnermichael howcurcumintargetsinflammatorymediatorsindiabetestherapeuticinsightsandpossiblesolutions
AT jeandetphilippe howcurcumintargetsinflammatorymediatorsindiabetestherapeuticinsightsandpossiblesolutions
AT sasoluciano howcurcumintargetsinflammatorymediatorsindiabetestherapeuticinsightsandpossiblesolutions